StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Total Liabilities by Quarter

Total Liabilities ($M)

QuarterlyAnnual

Novartis Total Liabilities: $79,585M in Q3 2026, up 27.3% from a year earlier.

Latest, Q3 2026
79,585
Period ended Sep 30, 2026
Change on a year earlier
+27.3%
62,537 in Q3 2025
History
35 quarters
Since Q4 2016
Sources
33
Documents cited below

Where the Q3 2026 figure comes from

“|| Total liabilities | 79 585 | 64 400”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Liabilities ($M)Year on yearSource
Q3 2026Sep 30, 202679,585+27.3%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 202680,087+28.5%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 202679,605+29.5%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 202564,400+10.8%Novartis 20-F (0001114448-26-000004, filed 2026-02-04) ↗
Q3 2025Sep 30, 202562,537+4.1%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2025Jun 30, 202562,341+12.1%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 202561,489+12.7%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2024Dec 31, 202458,120+9.3%Novartis 20-F (0001370368-25-000004, filed 2025-01-31) ↗
Q3 2024Sep 30, 202460,083-19.3%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2024Jun 30, 202455,603-5.8%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 202454,578-9.2%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2023Dec 31, 202353,195-8.3%Novartis 20-F (0001370368-24-000004, filed 2024-01-31) ↗
Q3 2023Sep 30, 202374,452+29.3%Novartis Form 6-K (0001370368-23-000068) ↗
Q2 2023Jun 30, 202359,048-1.4%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 202360,099-5.4%Novartis Form 6-K (0001370368-23-000046) ↗
Q4 2022Dec 31, 202258,030-9.3%Novartis 20-F (0001370368-23-000006, filed 2023-02-01) ↗

Cite this data

StockData. (2026). Novartis Total Liabilities ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-total-liab

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.